News Release

Research suggests new genetic target to treat cocaine addiction

Science Spotlight

This is Archived Content. This content is available for historical purposes only. It may not reflect the current state of science or language from the National Institute on Drug Abuse (NIDA). View current news releases on nida.nih.gov.

NIDA-funded research shows that a specific mutation in the CYFIP2 gene dramatically lowers responses to cocaine in a mouse model. The mutation appears to affect the CYFIP2 protein, a key player in processes underlying memory, learning, and habit formation.  This research provides a new target for research into potential medications to treat cocaine addiction.

Cocaine synapseCocaine synapse

For a copy of the study abstract, go to https://www.sciencemag.org/content/342/6165/1508.short.

For more information, contact the NIDA press office at media@nida.nih.gov or 301-443-6245.